Bittew Sisay Melese, Masresha Seteamlak Adane, Mulaw Getahun Fentaw, Yimam Mohammed Ahmed, Zimamu Abiot Alebel, Abriham Atnaf Alem, Kidie Atitegeb Abera
Woldia Comprehensive Specialized Hospital, Woldia, Ethiopia.
Department of Public Health, College of Health Science, Woldia University, Woldia, Ethiopia.
Front Glob Womens Health. 2024 Jul 10;5:1243280. doi: 10.3389/fgwh.2024.1243280. eCollection 2024.
The cells of the cervical epithelial wall are the source of the malignant tumor caused by the human papilloma virus (HPV) known as cervical cancer. In 2018, Ethiopia implemented the HPV vaccine specifically targeting girls aged 9-14 years. This vaccination initiative serves as an effective preventive measure against cervical cancer, provided that parents express a positive inclination to have their daughters vaccinated as part of the program.
The aim of the study was to assess parental willingness to vaccinate their daughters against human papillomavirus and its associated factors in Woldia town, Northeast Ethiopia.
A community-based cross-sectional study was conducted among 414 parents of daughters aged 9-14 years between 10 and 25 January 2023. Respondents were selected by a systematic sampling method and a face-to-face interview was conducted to collect data. Data were entered into Epi Data version 4.6 and exported to SPSS version 25 for analysis. Multivariable analyses were used to examine the association between dependent and independent variables. The adjusted odds ratio (AOR), 95% confidence interval (CI), and -value <0.05 were used to determine statistical significance.
A total of 410 study participants with a response rate of 99% were included in the study, and approximately 72.9% (95% CI: 68.3-77.2) of them were willing to vaccinate their daughters. This study found that parents with a family history of cervical cancer screening (AOR = 3.27, 95%; CI = 1.38-7.74), secondary and above educational status (AOR = 2.72, 95% CI = 1.29-5.73), good knowledge of the human papilloma virus vaccination (AOR = 3.00, 95% CI = 1.70-5.28), and favorable attitude toward the human papilloma virus vaccine (AOR = 4.40, 95% CI = 2.45-7.88) were significantly associated with parental willingness to vaccinate their daughters against human papilloma virus.
In this study, most parents were willing to vaccinate their daughters against human papilloma virus. The significant determinants of parental willingness to their daughter's human papilloma virus vaccination were family history of cervical cancer screening, level of education, and knowledge and attitude toward the human papilloma virus vaccine. Therefore, health information regarding the human papillomavirus vaccination with an emphasis on raising community awareness should be designed.
子宫颈上皮壁细胞是由人乳头瘤病毒（HPV）引起的恶性肿瘤（即宫颈癌）的源头。2018年，埃塞俄比亚实施了专门针对9至14岁女孩的HPV疫苗接种计划。只要父母表现出积极意愿让女儿参与该计划进行疫苗接种，这项接种举措就能成为预防宫颈癌的有效措施。
本研究旨在评估埃塞俄比亚东北部沃尔迪亚镇父母让女儿接种人乳头瘤病毒疫苗的意愿及其相关因素。
2023年1月10日至25日，在414名9至14岁女孩的父母中开展了一项基于社区的横断面研究。通过系统抽样方法选取受访者，并进行面对面访谈以收集数据。数据录入Epi Data 4.6版本，然后导出到SPSS 25版本进行分析。采用多变量分析来检验因变量和自变量之间的关联。调整后的优势比（AOR）、95%置信区间（CI）以及P值<0.05用于确定统计学意义。
本研究共纳入410名研究参与者，应答率为99%，其中约72.9%（95%CI：68.3 - 77.2）的父母愿意让女儿接种疫苗。本研究发现，有宫颈癌筛查家族史的父母（AOR = 3.27，95%；CI = 1.38 - 7.74）、受过中等及以上教育的父母（AOR = 2.72，95%CI = 1.29 - 5.73）、对人乳头瘤病毒疫苗接种有充分了解的父母（AOR = 3.00，95%CI = 1.70 - 5.28）以及对人乳头瘤病毒疫苗持积极态度的父母（AOR = 4.40，95%CI = 2.45 - 7.88）与父母让女儿接种人乳头瘤病毒疫苗的意愿显著相关。
在本研究中，大多数父母愿意让女儿接种人乳头瘤病毒疫苗。父母让女儿接种人乳头瘤病毒疫苗意愿的显著决定因素是宫颈癌筛查家族史、教育水平以及对人乳头瘤病毒疫苗的了解和态度。因此，应设计有关人乳头瘤病毒疫苗接种的健康信息，重点是提高社区意识。
